Drug Insights

Strategically Search Phenazopyridine on Synapse: A How-to Guide

12 March 2024
2 min read

Phenazopyridine, a diminutive molecule, serves primarily as an analgesic agent for urinary tract pain. Its mode of action involves alleviating the discomfort associated with urinary tract infections, bladder inflammation, and other related maladies. The inception of phenazopyridine's use dates back to 1928 and, since then, it has burgeoned into a popular choice for individuals experiencing arduous urination or other urinary tract symptoms. It is crucial to note, however, that while phenazopyridine effectively mitigates pain, it does not remedy the underlying condition that engenders the discomfort. Thus, healthcare professionals must supervise phenazopyridine use as it may interact adversely with other medications and engender potential side effects. Click on the image below to begin the exploration journey of Phenazopyridine through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Wegovy® Approved in the US for Heart Health in Obesity
Latest Hotspot
3 min read
Wegovy® Approved in the US for Heart Health in Obesity
12 March 2024
Wegovy® receives green light in the USA to diminish heart-related health hazards for those excessively heavy or with obesity coupled with confirmed heart conditions.
Read →
GLP-1R: Therapeutic Target for Obesity and Metabolic Disorders
GLP-1R: Therapeutic Target for Obesity and Metabolic Disorders
12 March 2024
In investigating obesity treatment, the GLP-1 receptor, key for managing Type 2 diabetes and heart disease, is a major focus.
Read →
BeiGene Reveals Swift FDA Nod for BRUKINSA Use in Recurrent or Stubborn Follicular Lymphoma Cases
Latest Hotspot
3 min read
BeiGene Reveals Swift FDA Nod for BRUKINSA Use in Recurrent or Stubborn Follicular Lymphoma Cases
12 March 2024
BeiGene, Ltd., a global oncology-focused biopharma, announced FDA's fast-track approval for its cancer drug BRUKINSA(zanubrutinib).
Read →
User-friendly Guide to Find Sodium bicarbonate on Synapse
Drug Insights
2 min read
User-friendly Guide to Find Sodium bicarbonate on Synapse
12 March 2024
Sodium bicarbonate, approved for medical use since 1981, continues to be a versatile treatment for many conditions.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.